CAS: 51387-90-7; 2-(2-Aminoethyl)-1-Methylpyrrolidine

该化合物是一种有机化合物,其特征是其含有五种含氮的乙基环结构,即五人组成的含氮乙基环循环.该化合物具有氨基乙基侧链和附属于pyrrolidine环氮原子的甲基组.该化合物一般无色可粉色黄色液体或固体,视其纯度和形态而定.氨基氨基化合物的存在具有基本特性,允许其参与各种化学反应,包括核生殖器替代和凝聚反应.该化合物溶于水和有机溶剂中,可在不同化学环境中使用.由于其结构特性,该化合物可能展示生物活动,有可能作为药物或农业化学品中的建筑块.在处理和储存时,应参考安全数据,如任何化学物质,以确保采取适当的防范措施.

结构式图片

相似化合物

2815574-04-8 422545-95-7 422545-96-8

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号76004-86-9 6-Chloro-N2-(3,... | CAS号422545-95-7 2-[(2S)-1-甲基吡咯烷...

合成工艺路线路线简述

    2-[2-(1-Methyl-Pyrrolidin-2-yl)-Ethyl]-Isoindole-1,3-Dione置于二氮烯体系中,用 乙醇 作为反应溶剂,化学反应 3.0H,反应生成 N-甲基-2-(2-氨乙基)-吡咯烷
    参考文献:一类新的组胺h(3)-受体拮抗剂:7,8,9,10-四氢-6H-环庚[b]喹啉的合成与构效关系.
    标题:一类新的组胺h(3)-受体拮抗剂:7,8,9,10-四氢-6H-环庚[b]喹啉的合成与构效关系.
    摘要:描述了人类h(3)受体的新型环庚喹啉拮抗剂的合成和生物学评估.研究了两个在11位带有氨基取代基或炔烃连接基的化合物.描述了氨基取代基的修饰,链长的优化和构象约束的影响.发现了几种对h(3)受体具有高亲和力和选择性的化合物.
    DOI:10.1016/s0960-894X(03)00356-1

    海关参考信息

    专利信息


    专利号:US-6413957-B1
    优先权日:1998-04-21
    标题:Methods of inhibiting cell proliferation using indeno [1,2-c]pyrazol-4-ones
    发明人:NUGIEL DAVID A; CARINI DAVID J; DI MEO SUSAN V; YUE EDDY W
    权利人:BRISTOL MYERS SUIBB PHARMA COM
    摘要:The present invention relates to the synthesis of a new class of indeno[1,2-c]pyrazol-4-ones of formula (I): n that are potent inhibitors of the class of enzymes known as cyclin dependent kinases, which relate to the catalytic subunits cdk1-7 and their regulatory subunits know as cyclins A-G. This invention also provides a novel method of treating cancer or other proliferative diseases by administering a therapeutically effective amount of one of these compounds or a pharmaceutically acceptable salt form thereof. Alternatively, one can treat cancer or other proliferative diseases by administering a therapeutically effective combination of one of the compounds of the present invention and one or more other known anti-cancer or anti-proliferative agents.

    专利号:US-9422321-B2
    优先权日:2010-09-07
    标题 :Pyrimidine nucleoside derivatives, synthesis methods and uses thereof for preparing anti-tumor and anti-virus medicaments
    发明人:CHANG JUNBIAO; AN HAOYUN; YU XUEJUN; GUO XIAOHE
    权利人:CHANG JUNBIAO; AN HAOYUN; YU XUEJUN; GUO XIAOHE; HIGH & NEW TECH RES CENTER HENAN ACAD OF SCIENCES; ZHENGZHOU GRANLEN PHARMATECH LTD; UNIV ZHENGZHOU
    摘要:The present invention relates to the field of pharmacochemistry. Disclosed are fluorinated and azido-substituted pyrimidine nucleoside derivatives, particularly compounds of the formula shown below: n nAlso disclosed are methods of preparation and uses for these compounds. The compounds can be used for preparing medicaments for treating diseases such as tumors and viral infections, and can be used separately or in combination with other medicaments. The compounds also have effective activity against diseases such as tumors and viral infections, while having few side effects, and thus have potential application value.

    专利号:US-7250435-B2
    优先权日:1999-10-20
    标 题:Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
    发明人:NUGIEL DAVID A; CARINI DAVID J; DI MEO SUSAN V; VIDWANS ANUP P; YUE EDDY
    权利人:BRISTOL MYERS SQUIBB PHARMA CO
    摘要:The present invention relates to the synthesis of a new class of indeno[1,2-c]pyrazol-4-ones of formula (I): n nthat are potent inhibitors of the class of enzymes known as cyclin dependent kinases, which relate to the catalytic subunits cdk1-7 and their regulatory subunits know as cyclins A-G.n n This invention also provides a novel method of treating cancer or other proliferative diseases by administering a therapeutically effective amount of one of these compounds or a pharmaceutically acceptable salt form thereof. Alternatively, one can treat cancer or other proliferative diseases by administering a therapeutically effective combination of one of the compounds of the present invention and one or more other known anti-cancer or anti-proliferative agents.

    专利号:US-7179918-B2
    优先权日:2001-06-11
    标 题:HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
    发明人:CANAN KOCH STACIE S; ALEXANDER THERESE N; BURKE BENJAMIN J; JEWELL TANYA M; KUCERA DAVID J; LINTON MARIA ANGELICA; MITCHELL JR LENNERT J; REICH SIEGFRIED H; SKALITZKY DONALD J; TATLOCK JOHN H; VARNEY MICHAEL D; VIRGIL SCOTT C; WEBBER STEPHEN E; WORLAND STEPHEN T; BARVIAN MARK; BOLTON GARY; BOYER JR FREDERICK EARL; MACHAK JEFFREY J; HOLLER TOD; MURPHY SEAN T; MELNICK MICHAEL; JOSYULA VARA PRASAD
    权利人:AGOURON PHARMA
    摘要:Compounds of the formula: n nwhere the formula variables are as defined herein, are disclosed that advantageously inhibit or block the biological activity of the HIV protease. These compounds, as well as pharmaceutical compositions containing these compounds, are useful for treating patients or hosts infected with the HIV virus. Intermediates and synthetic methods for preparing such compounds are also described.

    专利号:US-7468375-B2
    优先权日:2004-04-26
    标题:Inhibitors of the HIV integrase enzyme
    发明人:DRESS KLAUS RUPRECHT; HU QIYUE; JOHNSON TED WILLIAM; PLEWE MICHAEL BRUNO; TANIS STEVEN PAUL; WANG HAI; YANG ANLE; YIN CHUNFENG; ZHANG JUNHU
    权利人:PFIZER
    摘要:The present invention is directed to compounds of formula (I), and pharmaceutically acceptable salts and solvates thereof, their synthesis, and their use as modulators or inhibitors of the human immunodeficiency virus (“HIVâ€?) integrase enzyme.

    专利号:US-6407103-B2
    优先权日:1998-04-21
    标 题:Indeno [1,2-c] pyrazol-4-ones and their uses
    发明人:NUGIEL DAVID A; CARINI DAVID J; DI MEO SUSAN V; YUE EDDY W
    权利人:BRISTOL MYERS SQUIBB PHARMA CO
    摘要:The present invention relates to the synthesis of a new class of indeno[1,2-c]pyrazol-4-ones of formula (I):that are potent inhibitors of the class of enzymes known as cyclin dependent kinases, which relate to the catalytic subunits cdk1-9 and their regulatory subunits know as cyclins A-H.This invention also provides a novel method of treating cancer or other proliferative diseases by administering a therapeutically effective amount of one of these compounds or a pharmaceutically acceptable salt form thereof. Alternatively, one can treat cancer or other proliferative diseases by administering a therapeutically effective combination of one of the compounds of the present invention and one or more other known anti-cancer or anti-proliferative agents.
    上海先臣化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.xinchem.com
    企业联系电话:021-64606569👤
    📞上海先臣化工有限公司 ⚠️参考联系方式
    联系人:周陶敏
    电话:021-64606569


    邮箱:xinchem@xinchem.com
    通信地址: 兴梅路485号(中环科技园)闵行区
    邮编: 201100
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:兴梅路485号(中环科技园)闵行区
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    新沂市永诚化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.huilichemical.com
    企业联系电话:0516-88606028👤
    📞新沂市永诚化工有限公司 ⚠️参考联系方式
    联系人:李经理
    电话:0516-88606028
    手机:15952286050
    传真:0516-88608138
    邮箱:sales@huilichemical.com
    通信地址: 江苏新沂经济开发区经七路88号
    邮编: 221415
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏新沂经济开发区经七路88号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Alexandre Chigaev, Et Al. Galphas-Coupled Receptor Signaling Actively Down-Regulates Alpha4Beta1-Integrin Affinity: A Possible Mechanism For Cell De-Adhesion. Bmc Immunol. 2008 Jun 5:9:26.
    [参考文献]: D F Ranney, Et Al. Suppression Of Stimulating Cell Activity By Microtubule-Disrupting Alkaloids. J Supramol Struct. 1976;5(3):335-42.
    [参考文献]: Hirotoshi Morita, Et Al. Electrogenerated Chemiluminescence Derivatization Reagents For Carboxylic Acids And Amines In High-Performance Liquid Chromatography Using Tris(2,2'-Bipyridine)Ruthenium(Ii). Anal Chem. 2002 Apr 1;74(7):1584-9.
    [参考文献]: M C Stoll, Et Al. Veno-Venous Extracorporeal Membrane Oxygenation Therapy Of A Severely Injured Patient After Secondary Survey. Am J Emerg Med. 2014 Oct;32(10):1300.E1-2.
    [参考文献]: Xue-Bo Yin, Et Al. Dual-Cloud Point Extraction And Tertiary Amine Labeling For Selective And Sensitive Capillary Electrophoresis-Electrochemiluminescent Detection Of Auxins. J Chromatogr A. 2010 Feb 19;1217(8):1399-406.

    合成参考文献


    参考文献:10.1007/128_2011_200
    摘要:Miller BL. DCC in the development of nucleic acid targeted and nucleic acid inspired structures. Top Curr Chem. 2012;322():107–37. doi: 10.1007/128_2011_200.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知